ACE2 and COVID-19: In this regard, it was proposed that the lower expression of the viral receptor ACE2 in children in the nasal epithelium and serum protects them from severe COVID-19 (15, 16) and that patients with a lower expression level of ACE2 are less vulnerable to developing severe symptoms (26).